Accumulating evidence supports the pivotal role of KRAS not only in governing cancer cells’ autonomous mechanisms of proliferation, but also in controlling the immune landscape within the TME and in mediating immune escape and ultimately tumor progression. Here, KRAS is linked to neoplasm.